New antibiotics take aim at staph's rise

A Food and Drug Administration advisory panel will consider three proposed antibiotics designed to treat serious skin infections, including some caused by MRSA. The bacterium has sparked concern as the super bug has moved into community settings like schools and locker rooms in recent years after once being largely confined to hospital settings. But it's not clear if any of the three drugs will reach the bar for FDA approval because of safety concerns or questions about how well the drugs work compared with other available medications.